The company is evaluating whether the drug, which targets cardiac complications, might be used treat patients with other ...

Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01 ...

Analysis of the open label data from FLAMINGO-01 has commenced and has been conducted in a manner that maintains the study blind. A preliminary review of FLAMINGO-01 HLA data in both the HLA-A*02 ...

Bayern Munich have not worn red in the Champions League for a year-and-a-half now. The best red team in the world have not ...